These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 37612380)

  • 1. Primary aldosteronism: molecular medicine meets public health.
    Azizan EAB; Drake WM; Brown MJ
    Nat Rev Nephrol; 2023 Dec; 19(12):788-806. PubMed ID: 37612380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of primary aldosteronism.
    Reincke M; Bancos I; Mulatero P; Scholl UI; Stowasser M; Williams TA
    Lancet Diabetes Endocrinol; 2021 Dec; 9(12):876-892. PubMed ID: 34798068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling.
    Omura M; Sasano H; Fujiwara T; Yamaguchi K; Nishikawa T
    Metabolism; 2002 Mar; 51(3):350-5. PubMed ID: 11887172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.
    Pitsava G; Faucz FR; Stratakis CA; Hannah-Shmouni F
    Curr Cardiol Rep; 2022 Sep; 24(9):1189-1195. PubMed ID: 35841527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel genetic determinants of adrenal aldosterone regulation.
    Azizan EA; Brown MJ
    Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):209-17. PubMed ID: 26992195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues.
    Zhou J; Lam B; Neogi SG; Yeo GS; Azizan EA; Brown MJ
    Hypertension; 2016 Dec; 68(6):1424-1431. PubMed ID: 27777363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disordered CYP11B2 Expression in Primary Aldosteronism.
    Gomez-Sanchez CE; Kuppusamy M; Reincke M; Williams TA
    Horm Metab Res; 2017 Dec; 49(12):957-962. PubMed ID: 29202495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of Aldosterone Biosynthesis and its Action.
    Gao X; Yamazaki Y; Tezuka Y; Omata K; Ono Y; Morimoto R; Nakamura Y; Suzuki T; Satoh F; Sasano H
    Tohoku J Exp Med; 2021 May; 254(1):1-15. PubMed ID: 34011803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and treatment of primary aldosteronism.
    Zennaro MC; Boulkroun S; Fernandes-Rosa FL
    Nat Rev Endocrinol; 2020 Oct; 16(10):578-589. PubMed ID: 32724183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism.
    Brown RD; Kem DC; Hogan MJ; Hegstad RL
    Metabolism; 1984 Aug; 33(8):734-8. PubMed ID: 6748946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary aldosteronism.
    Gordon RD
    J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal Anion Channels: New Roles in Zona Glomerulosa Physiology and in the Pathophysiology of Primary Aldosteronism.
    Stölting G; Scholl UI
    Handb Exp Pharmacol; 2024; 283():59-79. PubMed ID: 37495852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, diagnosis and outcomes of treatment for primary aldosteronism.
    Yang Y; Reincke M; Williams TA
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101365. PubMed ID: 31837980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colocalization of Wnt/β-Catenin and ACTH Signaling Pathways and Paracrine Regulation in Aldosterone-producing Adenoma.
    De Sousa K; Abdellatif AB; Giscos-Douriez I; Meatchi T; Amar L; Fernandes-Rosa FL; Boulkroun S; Zennaro MC
    J Clin Endocrinol Metab; 2022 Jan; 107(2):419-434. PubMed ID: 34570225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.
    Seccia TM; Caroccia B; Gomez-Sanchez EP; Gomez-Sanchez CE; Rossi GP
    Endocr Rev; 2018 Dec; 39(6):1029-1056. PubMed ID: 30007283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperaldosteronism].
    Scholl UI
    Internist (Berl); 2021 Mar; 62(3):245-251. PubMed ID: 33599784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old and new genes in primary aldosteronism.
    Boulkroun S; Fernandes-Rosa FL; Zennaro MC
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101375. PubMed ID: 32007424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological and Pathological Roles in Human Adrenal of the Glomeruli-Defining Matrix Protein NPNT (Nephronectin).
    Teo AE; Garg S; Johnson TI; Zhao W; Zhou J; Gomez-Sanchez CE; Gurnell M; Brown MJ
    Hypertension; 2017 Jun; 69(6):1207-1216. PubMed ID: 28416583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.